AcelRx Stock Jumps 20% After Positive Results From Its Trial On ARX-04

By: via Benzinga
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) disclosed that its investigational product candidate ARX-04 provided solid tolerance level ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.